Quality and Pharmacovigilance Agreements. Within ninety (90) days after Regulatory Approval in Canada, the parties will begin to negotiate in good faith a mutually acceptable quality agreement and pharmacovigilance agreement with respect to the Product including the matters set forth in Section 15.1 above.
Appears in 3 contracts
Samples: Distribution and License Agreement (Rosewind CORP), Distribution and License Agreement (Rosewind CORP), Distribution and License Agreement (Vyrix Pharmaceuticals, Inc.)
Quality and Pharmacovigilance Agreements. Within ninety (90) days after Regulatory Approval in Canada, the parties will begin to negotiate in good faith a mutually acceptable quality agreement and pharmacovigilance agreement with respect to the Product including the matters set forth in Section 15.1 16.1 above.
Appears in 2 contracts
Samples: Distribution and License Agreement (Immuron LTD), Distribution and License Agreement (Immuron LTD)
